BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31176613)

  • 1. Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
    Schulz GB; Grimm T; Sers C; Riemer P; Elmasry M; Kirchner T; Stief CG; Karl A; Horst D
    Urol Oncol; 2019 Aug; 37(8):530.e9-530.e18. PubMed ID: 31176613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and the Prognostic Value of Biglycan in Gastric Cancer.
    Hu S; Li P; Wang C; Liu X
    Comput Math Methods Med; 2022; 2022():2656480. PubMed ID: 36110576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BGN and THBS2 as metastasis-specific biomarkers and poor survival key regulators in human colon cancer by integrated analysis.
    He Z; Lin J; Chen C; Chen Y; Yang S; Cai X; He Y; Liu S
    Clin Transl Med; 2022 Nov; 12(11):e973. PubMed ID: 36377223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
    Ottley EC; Pell R; Brazier B; Hollidge J; Kartsonaki C; Browning L; O'Neill E; Kiltie AE
    J Pathol Clin Res; 2020 Oct; 6(4):238-251. PubMed ID: 32374509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
    Jacobsen F; Kraft J; Schroeder C; Hube-Magg C; Kluth M; Lang DS; Simon R; Sauter G; Izbicki JR; Clauditz TS; Luebke AM; Hinsch A; Wilczak W; Wittmer C; Büscheck F; Höflmayer D; Minner S; Tsourlakis MC; Huland H; Graefen M; Budäus L; Thederan I; Salomon G; Schlomm T; Melling N
    Neoplasia; 2017 Sep; 19(9):707-715. PubMed ID: 28830008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
    Tong H; Li T; Gao S; Yin H; Cao H; He W
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.
    Subbarayan K; Seliger B
    Curr Cancer Drug Targets; 2019; 19(3):210-221. PubMed ID: 29984655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers.
    Zhao SF; Yin XJ; Zhao WJ; Liu LC; Wang ZP
    Oncol Lett; 2020 Mar; 19(3):1673-1682. PubMed ID: 32194659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness.
    Pinto F; Santos-Ferreira L; Pinto MT; Gomes C; Reis CA
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.
    Niedworok C; Panitz M; Szarvas T; Reis H; Reis AC; Szendröi A; Nyirády P; Szasz AM; Módos O; Rübben H; Vom Dorp F
    J Urol; 2016 Jun; 195(6):1690-6. PubMed ID: 26678957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis.
    Li H; Zhong A; Li S; Meng X; Wang X; Xu F; Lai M
    Sci Rep; 2017 Jul; 7(1):4915. PubMed ID: 28687755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
    Subbarayan K; Leisz S; Wickenhauser C; Bethmann D; Massa C; Steven A; Seliger B
    Oncoimmunology; 2018; 7(4):e1373233. PubMed ID: 29632715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
    Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
    Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
    Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
    Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of biglycan and decorin expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma.
    Liu M; Wang W; Piao S; Shen Y; Li Z; Ding W; Li J; Saiyin W
    J Oral Pathol Med; 2023 Jan; 52(1):20-28. PubMed ID: 36308714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy.
    Cong L; Maishi N; Annan DA; Young MF; Morimoto H; Morimoto M; Nam JM; Hida Y; Hida K
    Breast Cancer Res; 2021 May; 23(1):51. PubMed ID: 33966638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of BGN positive fibroblasts as a driving factor for colorectal cancer and development of its related prognostic model combined with machine learning.
    Hu S; Xiao Q; Gao R; Qin J; Nie J; Chen Y; Lou J; Ding M; Pan Y; Wang S
    BMC Cancer; 2024 Apr; 24(1):516. PubMed ID: 38654221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():765569. PubMed ID: 35154268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.